These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5140491)

  • 1. Cytological responses in tumor-bearing mice to phosphomucolipid.
    Mita A; Nakazawa M
    Gan; 1971 Dec; 62(6):459-70. PubMed ID: 5140491
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological evidences for proliferation and migration of lymphocytes induced by administration of potent antitumor phosphomucolipid in tumor-bearing mice.
    Mita A
    Rev Eur Etud Clin Biol; 1972 Nov; 17(9):860-7. PubMed ID: 4569609
    [No Abstract]   [Full Text] [Related]  

  • 3. Carcinoma infection and immune systems of Ehrlich ascites carcinoma-bearing mice treated with structurally similar sulfonium compounds.
    Nakajima K; Nakajima Y
    Biosci Biotechnol Biochem; 2011; 75(4):808-11. PubMed ID: 21512215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution of intraperitoneally injected colloidal particles in animals bearing implanted tumors of the mediastinum.
    Adlersberg L; Singer JM; Edberg SC
    J Reticuloendothel Soc; 1973 Dec; 14(6):571-86. PubMed ID: 4775530
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphotoxic effect of cyclophosphamide in therapy of Ehrlich ascites carcinoma in mice.
    Culo F; Allegretti N; Marusić M
    J Natl Cancer Inst; 1977 Jun; 58(6):1759-64. PubMed ID: 869969
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of the Landschütz ascites carcinoma and ascitic fluid on macrophage activity in C. parvum-injected mice.
    McIntosh LC; Pugh-Humphreys RG; Thomson AW
    Br J Cancer; 1981 Apr; 43(4):496-504. PubMed ID: 7236491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual effects of indoleamine 2,3-dioxygenase inhibitors on the therapeutic effects of cyclophosphamide and cycloplatam on Ehrlich ascites tumor in mice.
    Bogdanova LA; Morozkova TS; Amitina SA; Mazhukin DG; Nikolin VP; Popova NA; Kaledin VI
    Bull Exp Biol Med; 2014 Aug; 157(4):506-9. PubMed ID: 25110094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression induced with cell-free fluid of Ehrlich carcinoma ascites and its fractions.
    Yamazaki H; Nitta K; Umezawa H
    Gan; 1973 Feb; 64(1):83-92. PubMed ID: 4577968
    [No Abstract]   [Full Text] [Related]  

  • 9. Some characteristics of strain SJL-JDg mice.
    Crispens CG
    Lab Anim Sci; 1973 Jun; 23(3):408-13. PubMed ID: 4351481
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
    Olinescu A; Hristescu S; Mazilu E
    Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The theta antigenicity of lymphoid organs of mice bearing the Ehrlich ascites tumor.
    Loring M; Schlesinger M
    Cancer Res; 1970 Aug; 30(8):2204-7. PubMed ID: 5466693
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistance and susceptibility to tumours. VI. Reaction of labelled lymphoid cells transferred into the site of previously implanted carcinoma.
    Dvorák R; Lindner J
    Neoplasma; 1971; 18(1):63-86. PubMed ID: 5575435
    [No Abstract]   [Full Text] [Related]  

  • 13. [Characteristics of the reaction of the parathymic lymph nodes to pathogenic influences].
    Aseeva ND; Sakharova NG
    Ontogenez; 1986; 17(5):538-40. PubMed ID: 3785875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor growth enhancement and systemic responses of Ehrlich ascites carcinoma following intermittent whole body hyperthermia.
    Lahiri T; Roy D; Sen S
    Neoplasma; 1986; 33(2):207-16. PubMed ID: 3012385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of ascitic fluid on the growth of Ehrlich tumor and Lewis carcinoma].
    Donenko FV; Kabieva AO; Moroz LV
    Biull Eksp Biol Med; 1992 Jul; 114(8):191-3. PubMed ID: 1467491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversibility of the immunodepression due to Ehrlich ascites carcinoma.
    Mocarelli P; Villa ML; Garotta G; Porta C; Bigi G; Clerici E
    J Immunol; 1973 Sep; 111(3):973-5. PubMed ID: 4582265
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on immune response of experimental tumors--observations on the immune response of lymph nodes of mice bearing implanted Ehrlich ascitic tumor or sarcoma 180 (author's transl)].
    Chen QF; Zhou SL; Liu QR
    Zhonghua Zhong Liu Za Zhi; 1980 Sep; 2(3):193-6. PubMed ID: 7227183
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular antibody in mice bearing Ehrlich cancer. II. Properties of lymphoid cells from sensitized animal.
    Hara S
    Acta Med Okayama (1952); 1965 Apr; 19(2):99-106. PubMed ID: 4221944
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular antibody in mice bearing Ehrlich cancer. I. A quantitative study on antitumor activity of cellular antibody in vitro.
    Hara S
    Acta Med Okayama (1952); 1965 Apr; 19(2):91-8. PubMed ID: 4221891
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhancement of cytogenetic damage and of antineoplastic effect by caffeine in Ehrlich ascites tumor cells treated with cyclophosphamide in vivo.
    Mourelatos D; Dozi-Vassiliades J; Kotsis A; Gourtsas C
    Cancer Res; 1988 Mar; 48(5):1129-31. PubMed ID: 3342394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.